Immunogenicity of protein therapeutics AS De Groot, DW Scott Trends in immunology 28 (11), 482-490, 2007 | 628 | 2007 |
Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes” AS De Groot, L Moise, JA McMurry, E Wambre, L Van Overtvelt, ... Blood, The Journal of the American Society of Hematology 112 (8), 3303-3311, 2008 | 456 | 2008 |
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance RA Maldonado, RA LaMothe, JD Ferrari, AH Zhang, RJ Rossi, PN Kolte, ... Proceedings of the National Academy of Sciences 112 (2), E156-E165, 2015 | 434 | 2015 |
Activation-induced apoptosis in lymphocytes DR Green, DW Scott Current opinion in immunology 6 (3), 476-487, 1994 | 329 | 1994 |
Death the Fas way: regulation and pathophysiology of CD95 and its ligand K Sharma, RX Wang, LY Zhang, DL Yin, XY Luo, JC Solomon, RF Jiang, ... Pharmacology & therapeutics 88 (3), 333-347, 2000 | 314 | 2000 |
Regulation of the G1 phase of the mammalian cell cycle D Donjerkovic, DW Scott Cell research 10 (1), 1-16, 2000 | 244 | 2000 |
Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins TC Lei, DW Scott Blood 105 (12), 4865-4870, 2005 | 198 | 2005 |
Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T-and B-cell responses YC Kim, AH Zhang, Y Su, SA Rieder, RJ Rossi, RA Ettinger, KP Pratt, ... Blood, The Journal of the American Society of Hematology 125 (7), 1107-1115, 2015 | 174 | 2015 |
FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T-and B-cell responses to FVIII J Yoon, A Schmidt, AH Zhang, C Königs, YC Kim, DW Scott Blood, The Journal of the American Society of Hematology 129 (2), 238-245, 2017 | 147 | 2017 |
Tregitope update: mechanism of action parallels IVIg LP Cousens, R Tassone, BD Mazer, V Ramachandiran, DW Scott, ... Autoimmunity Reviews 12 (3), 436-443, 2013 | 143 | 2013 |
Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu. DW Scott, D Livnat, CA Pennell, P Keng The Journal of experimental medicine 164 (1), 156-164, 1986 | 142 | 1986 |
Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases MEF Melo, J Qian, M El-Amine, RK Agarwal, N Soukhareva, Y Kang, ... The Journal of Immunology 168 (9), 4788-4795, 2002 | 140 | 2002 |
Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc. G Fischer, SC Kent, L Joseph, DR Green, DW Scott The Journal of experimental medicine 179 (1), 221-228, 1994 | 140 | 1994 |
Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis RK Agarwal, Y Kang, E Zambidis, DW Scott, CC Chan, RR Caspi The Journal of clinical investigation 106 (2), 245-252, 2000 | 139 | 2000 |
In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity LP Cousens, N Najafian, F Mingozzi, W Elyaman, B Mazer, L Moise, ... Journal of clinical immunology 33, 43-49, 2013 | 131 | 2013 |
Role of IgD in the immune response and tolerance. I. Anti-delta pretreatment facilitates tolerance induction in adult B cells in vitro. DW Scott, JE Layton, GJ Nossal The Journal of experimental medicine 146 (6), 1473-1483, 1977 | 131 | 1977 |
Activation-induced cell death in B lymphocytes D DONJERKOVIć, DW Scott Cell Research 10 (3), 179-192, 2000 | 128 | 2000 |
T cells commit suicide, but B cells are murdered! DW Scott, T Grdina, Y Shi Journal of immunology (Baltimore, Md.: 1950) 156 (7), 2352-2356, 1996 | 117 | 1996 |
Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes DM Brown, GL Warner, JE Alés-Martínez, DW Scott, RP Phipps Clinical immunology and immunopathology 63 (3), 221-229, 1992 | 114 | 1992 |
Epitope-specific tolerance induction with an engineered immunoglobulin. ET Zambidis, DW Scott Proceedings of the National Academy of Sciences 93 (10), 5019-5024, 1996 | 111 | 1996 |